Janet L. Kwiatkowski

High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.

A. Eggert, N. Ikegaki, G. Brodeur, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Harold Lehmann, Michael A Kraut, Fenella J Kirkham, 2014, The New England journal of medicine.

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status.

T. Haferlach, S. Schnittger, W. Kern, 2010, Blood.

Acute silent cerebral ischemic events in children with sickle cell anemia.

M. Kraut, R. McKinstry, R. Ichord, 2013, JAMA neurology.

Schwann cell-conditioned medium promotes neuroblastoma survival and differentiation.

J. Rutkowski, G. Tennekoon, G. Brodeur, 1998, Cancer research.

Lymphoblastic Leukemia (all) Molecular Study of Minimal Residual Disease (mrd) in Adult Acute Improved Risk Classification for Risk-specific Therapy Based on The

T. Barbui, A. Bosi, A. Gallamini, 2022 .

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

R. Gascoyne, L. Sehn, J. Connors, 2007, Blood.